Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

ClinicalTrials.gov ID: NCT02452866

Public ClinicalTrials.gov record NCT02452866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Prospective, Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole, for the Treatment of Women and Postmenarchal Adolescent Girls With Bacterial Vaginosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, multi-center, prospective, open-label study to evaluate the safety of SYM-1219 granules containing 2 grams of secnidazole in women and postmenarchal adolescent girls with bacterial vaginosis.

Study identification

NCT ID
NCT02452866
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Symbiomix Therapeutics
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2015 (Type not available)
Primary completion
Oct 2015 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
Apr 13, 2021

2015

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294 —
Not listed Phoenix Arizona 85018 —
Not listed Jonesboro Arkansas 72401 —
Not listed La Mesa California 91942 —
Not listed San Diego California 92108 —
Not listed Colorado Springs Colorado 80907 —
Not listed Denver Colorado 80209 —
Not listed Groton Connecticut 06340 —
Not listed Clearwater Florida 33759 —
Not listed Leesburg Florida 34748 —
Not listed Miami Florida 33186 —
Not listed North Miami Florida 33161 —
Not listed Plantation Florida 33324 —
Not listed Wellington Florida 33414 —
Not listed Atlanta Georgia 30312 —
Not listed Columbus Georgia 31904 —
Not listed Roswell Georgia 30075 —
Not listed Shawnee Mission Kansas 66218 —
Not listed Baltimore Maryland 21224 —
Not listed Fall River Massachusetts 02720 —
Not listed Grand Rapids Michigan 49503 —
Not listed Kalamazoo Michigan 49009 —
Not listed Saginaw Michigan 48604 —
Not listed Plainsboro New Jersey 08536 —
Not listed New Bern North Carolina 28562 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Columbus Ohio 43213 —
Not listed Columbus Ohio 43231 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Philadelphia Pennsylvania 19114 —
Not listed Myrtle Beach South Carolina 29572 —
Not listed Jackson Tennessee 38305 —
Not listed Corpus Christi Texas 78414 —
Not listed Dallas Texas 75231 —
Not listed Houston Texas 77054 —
Not listed San Antonio Texas 78229 —
Not listed Norfolk Virginia 23507 —
Not listed Virginia Beach Virginia 23456 —
Not listed Seattle Washington 98104 —
Not listed Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02452866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02452866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →